Article info

Original research
Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score

Authors

  1. Correspondence to Dr David J Pinato; david.pinato{at}imperial.ac.uk
View Full Text

Citation

Dettorre GM, Dolly S, Loizidou A On behalf of OnCovid study group, et al
Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score

Publication history

  • Accepted February 5, 2021
  • First published March 22, 2021.
Online issue publication 
February 10, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.